HROW: Harrow, Inc. Stock

by  •  • Comments Off on HROW: Harrow, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 571.77
Enterprise Value ($M) 687.03
Book Value ($M) 60.21
Book Value / Share 1.70
Price / Book 9.50
NCAV ($M) -109.87
NCAV / Share -3.11
Price / NCAV -5.20

Profitability (mra)
Return on Invested Capital (ROIC) -0.12
Return on Assets (ROA) -0.14
Return on Equity (ROE) -1.46

Liquidity (mrq)
Quick Ratio 2.75
Current Ratio 3.00

Balance Sheet (mrq) ($M)
Current Assets 125.46
Assets 295.54
Liabilities 235.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 130.19
Operating Income 0.81
Net Income -24.41
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 3.84
Cash from Investing -152.55
Cash from Financing 126.53

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Kaufman Daniel Louis 5.43 1.18
02-13 13G Vanguard Group Inc 5.15
02-09 13G/A Opaleye Management Inc. 10.88 1.19
01-29 13G BlackRock Inc. 6.30 436.54
01-09 13G Private Capital Management, LLC 10.34
08-18 13D/A Baum Mark L 9.50 47.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 135,801 492,574 27.57
2024-05-16 77,225 474,512 16.27
2024-05-15 160,457 940,135 17.07
2024-05-14 539,123 757,002 71.22
2024-05-13 251,768 832,176 30.25

(click for more detail)

Similar Companies
GRTX – Galera Therapeutics, Inc. HCWB – HCW Biologics Inc.
HRMY – Harmony Biosciences Holdings, Inc. IKNA – Ikena Oncology, Inc.
IMRX – Immuneering Corporation


Financial data and stock pages provided by
Fintel.io